Oncology Institute Inc (The) - Warrants (15/11/2026)

Oncology Institute Inc (The) - Warrants (15/11/2026)

TOIIW

Get informed when a big investor buys or sells

+ Follow
Market Cap$48.84M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Oncology Institute Inc (The) - Warrants (15/11/2026)Oncology Institute Inc (The) - Warrants (15/11/2026)-22.1-146%--4.3
$-4.71

Current Fair Value

10035.4% downside

Overvalued by 10035.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$48.84 Million
Enterprise Value$114.38 Million
Dividend Yield$- (-)
Earnings per Share$-0.54
Beta0.42
Outstanding Shares1,030,314,930

Return

Return on Equity145.67%ROE
Return on Assets-20.36%
Return on Invested Capital-35.30%

Valuation & Multiples

P/E Ratio-22.1P/E Ratio
PEG52.06PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.05Price to Book Ratio
Enterprise Value to Revenue0.19
Enterprise Value to EBIT-3.89
Enterprise Value to Net Income-4
Total Debt to Enterprise0.93
Debt to Equity-4.28Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 11, 2026
EPS Estimate
$-0.06
Average shareholder expectation
Revenue Estimate
$155.28 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls109,1000%
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.40%▲ 0.02%
Total Invested$169,269▼ 0.89%
Investors Holding14▲ 1.00%

ESG Score

No data

About DFP Healthcare Acquisitions Corp

641 employees
CEO: Daniel Virnich

DFP Healthcare Acquisitions Corp. is a blank check company. The Company’s business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more ...